News that has caught Rachael Babin’s eye this week
Browsing: Editor’s Choice
Implications of deferring cancer prevention services in connection to COVID-19: The case of Ethiopia
Most African countries including Ethiopia have recently adopted public health measures to contain the COVID-19…
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with relapsed ovarian cancer and BRCA mutation
Maintenance therapy with olaparib extended overall survival by nearly 13 months (12.9) compared with placebo…
Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation…
ASCO 2020: New class of targeted radioactive treatment effective for men with metastatic prostate cancer
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the interim…
World-first saliva test detects hidden throat cancer
A simple saliva test developed by Queensland University of Technology (QUT) biomedical scientists has detected…
Antihistamines may help patients with malignant melanoma
Can a very common allergy medicine improve survival among patients suffering from the serious skin…
More than 10,000 job losses, billions in lost revenue: coronavirus will hit Australia’s research capacity harder than the GFC
Frank Larkins, University of Melbourne and Kylie Walker, Australian National University Australia’s researchers have answered…
Breast cancer ‘signature’ predicts response to new drug class
Melbourne researchers have developed a new way to pinpoint which breast cancers will respond to…
Killing ‘sleeper cells’ may enhance breast cancer therapy
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer…
Targeting toughest cancers with new treatment
In an Australian first, researchers at the South Australian Medical Research Institute (SAHMRI) are adopting new ways…